Results 201 to 210 of about 19,910 (273)

High-Resolution Quantification of Two-Way Nanobody Synergy Using Automated Liquid Handling and Computational Modeling. [PDF]

Bio Protoc
Bourgeois NM, Bell SW, Olivier JP, Rout MP, Aitchison JD, Mast FD.   +5 more
europepmc   +1 more source

Crystal structure and nanobodies against domain 3 of the malaria parasite fusogen Plasmodium falciparum HAP2. [PDF]

Biochem J
Lyons FMT, Chmielewski J, Chan LJ, Gabriela M, Chan RWB, Adair A, Tong J, Pymm P, Zeglinski K, Gouil Q, Tham WH, Dietrich MH.   +11 more
europepmc   +1 more source

Nanobody-Mediated c-MYC Degradation Inhibits Tumor Cell Progression. [PDF]

MedComm (2020)
Xue Y, Jiang H, Zong Z, Tian X, Miao Z, Li T, Wei Y, Deng H.   +7 more
europepmc   +1 more source

A highly potent and broadly accessible bispecific nanobody for the treatment of ebola virus infections. [PDF]

PLoS Pathog
Bu F, Ye G, Morsheimer K, Turner-Hubbard H, Eaton B, Anantpadma M, Bheemanapally K, Tan C, Davey R, Li F.   +9 more
europepmc   +1 more source

Antibody-enabled structural biology and AI-driven antibody design. [PDF]

Front Pharmacol
Ashraf KU, Erramilli SK.
europepmc   +1 more source

Susceptibility of broad reactivity nanobodies to resistance mutations in the S2 domain of SARS-CoV-2 predicted by yeast display deep mutational scanning. [PDF]

Front Immunol
Ball CR, Ramage W, Mate R, Hufton SE.
europepmc   +1 more source

Constitutive activity of an atypical chemokine receptor revealed by inverse agonistic nanobodies. [PDF]

Nat Commun
Perez Almeria CV, Otun O, Schlimgen R, Lamme TD, Di Niro L, Crudden C, Bebelman JP, Youssef N, Musli L, Jenjak S, Bobkov V, Drube J, Hoffmann C, Volkman BF, Granier S, Bechara C, Siderius M, Heukers R, Schafer CT, Smit MJ.   +19 more
europepmc   +1 more source

Bimodal nanobody agents for cancer imaging and potential intraoperative guidance: a systematic review. [PDF]

J Nanobiotechnology
Mammadbayli N, Altunay B, Peña Q, Kobzev D, Morgenroth A, Sadeghzadeh M, Lammers T, Mottaghy FM, Schäfer L, Lütje S.   +9 more
europepmc   +1 more source

Unique antibodies across the animal kingdom (birds, camelids, and sharks): therapeutic potential against human respiratory viral infections. [PDF]

Front Immunol
Basabrain AA, Alandijany TA.
europepmc   +1 more source

A trans-activating transduction peptide fused nanobody targeting viral nonstructural protein NS4B inhibits bovine viral diarrhea virus replication. [PDF]

Front Immunol
Zhao B, Lv Z, Fan W, Zhang Y, Wei S, Fang J, Huang N, Chen X, Wang L, Qi X.   +9 more
europepmc   +1 more source